Breast cancer biomarkers: proteomic discovery and translation to clinically relevant assays (Q38068925)

28 August 2017

1 reference

title

Breast cancer biomarkers: proteomic discovery and translation to clinically relevant assays (English)

1 reference

28 August 2017

0 references

Liping Chung

1

1 reference

PubMed ID

23256671

28 August 2017

Robert C Baxter

series ordinal

2

1 reference

28 August 2017

1 December 2012

1 reference

Expert Review of Proteomics

28 August 2017

1 reference

28 August 2017

9

1 reference

28 August 2017

6

1 reference

28 August 2017

599-614

1 reference

28 August 2017

Global cancer statistics

1 reference

Personalized treatment of early-stage breast cancer: present concepts and future directions

21 January 2018

1 reference

Molecular portraits of human breast tumours

21 January 2018

1 reference

Gene expression profiling in breast cancer: classification, prognostication, and prediction

21 January 2018

1 reference

Screening for cancer with molecular markers: progress comes with potential problems

21 January 2018

1 reference

Secreted proteins as a fundamental source for biomarker discovery

21 January 2018

1 reference

Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine

21 January 2018

1 reference

Cancer biomarker discovery: Opportunities and pitfalls in analytical methods

21 January 2018

1 reference

Proteomic databases and tools to decipher post-translational modifications

21 January 2018

1 reference

Phosphoproteomics in cancer

21 January 2018

1 reference

Deep and highly sensitive proteome coverage by LC-MS/MS without prefractionation.

21 January 2018

1 reference

CA 15-3: uses and limitation as a biomarker for breast cancer

21 January 2018

1 reference

Serum tumor markers in breast cancer: are they of clinical value?

21 January 2018

1 reference

Breast cancer screening and biomarkers

21 January 2018

1 reference

Early detection of recurrent breast cancer using metabolite profiling

21 January 2018

1 reference

Can some patients avoid adjuvant chemotherapy for early-stage breast cancer?

21 January 2018

1 reference

Use of standard markers and incorporation of molecular markers into breast cancer therapy: Consensus recommendations from an International Expert Panel

21 January 2018

1 reference

BRCA1 and BRCA2: different roles in a common pathway of genome protection

21 January 2018

1 reference

Systemic therapy options in BRCA mutation-associated breast cancer

21 January 2018

1 reference

Cytologic findings and protein expression profiles associated with ductal carcinoma of the breast in ductal lavage specimens using surface-enhanced laser desorption and ionization-time of flight mass spectrometry

21 January 2018

1 reference

Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer

21 January 2018

1 reference

Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors

21 January 2018

1 reference

iTRAQ-based proteomic profiling of breast cancer cell response to doxorubicin and TRAIL.

21 January 2018

1 reference

Establishment of in-vitro models of chemotherapy resistance

21 January 2018

1 reference

Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma

21 January 2018

1 reference

Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy

21 January 2018

1 reference

Serum proteomic patterns for detection of prostate cancer

21 January 2018

1 reference

Mining the plasma proteome for cancer biomarkers

21 January 2018

1 reference

HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples

21 January 2018

1 reference

Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database

21 January 2018

1 reference

Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer

21 January 2018

1 reference

Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer.

21 January 2018

1 reference

Combined experimental and statistical strategy for mass spectrometry based serum protein profiling for diagnosis of breast cancer: a case-control study

21 January 2018

1 reference

Breast-tissue sampling for risk assessment and prevention

21 January 2018

1 reference

Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer

21 January 2018

1 reference

Nipple aspirate fluid proteome of healthy females and patients with breast cancer

21 January 2018

1 reference

The intraductal approach to breast cancer biomarker discovery.

21 January 2018

1 reference

Proteomics-driven cancer biomarker discovery: looking to the future.

21 January 2018

1 reference

SELDI-MS-based expression profiling of ductal invasive and lobular invasive human breast carcinomas

21 January 2018

1 reference

Molecular pathology in epidemiologic studies: a primer on key considerations

21 January 2018

1 reference

Direct cancer tissue proteomics: a method to identify candidate cancer biomarkers from formalin-fixed paraffin-embedded archival tissues

21 January 2018

1 reference

Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS

21 January 2018

1 reference

Profiling of apoptotic changes in human breast cancer cells using SELDI-TOF mass spectrometry

21 January 2018

1 reference

Proteomic profiling of primary breast cancer predicts axillary lymph node metastasis.

21 January 2018

1 reference

Laser capture microdissection applications in breast cancer proteomics

21 January 2018

1 reference

Proteomic patterns of tumour subsets in non-small-cell lung cancer

21 January 2018

1 reference

Modelling breast cancer: one size does not fit all.

21 January 2018

1 reference

Cancer proteomics by quantitative shotgun proteomics

21 January 2018

1 reference

Relevance of breast cancer cell lines as models for breast tumours: an update

21 January 2018

1 reference

From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis

21 January 2018

1 reference

Proteomics by mass spectrometry: approaches, advances, and applications

21 January 2018

1 reference

Comparison of protein expression profiles of different stages of lymph nodes metastasis in breast cancer

21 January 2018

1 reference

Biomarkers of breast cancer apoptosis induced by chemotherapy and TRAIL.

21 January 2018

1 reference

Identification of differentially expressed proteins in triple-negative breast carcinomas using DIGE and mass spectrometry

21 January 2018

1 reference

Discovery and verification of protein differences between Er positive/Her2/neu negative breast tumor tissue and matched adjacent normal breast tissue

21 January 2018

1 reference

Selected reaction monitoring applied to proteomics.

21 January 2018

1 reference

Targeted proteomics by selected reaction monitoring mass spectrometry: applications to systems biology and biomarker discovery

21 January 2018

1 reference

Towards clinical applications of selected reaction monitoring for plasma protein biomarker studies

21 January 2018

1 reference

Multiplexed quantification of estrogen receptor and HER2/Neu in tissue and cell lysates by peptide immunoaffinity enrichment mass spectrometry

21 January 2018

1 reference

Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.

21 January 2018

1 reference

MRM screening/biomarker discovery with linear ion trap MS: a library of human cancer-specific peptides

21 January 2018

1 reference

Quantitative analysis of energy metabolic pathways in MCF-7 breast cancer cells by selected reaction monitoring assay

21 January 2018

1 reference

Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study

21 January 2018

1 reference

Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis

21 January 2018

1 reference

Novel biomarkers of human growth hormone action from serum proteomic profiling using protein chip mass spectrometry.

21 January 2018

1 reference

Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.

21 January 2018

1 reference

Surface plasmon resonance imaging in arrays coupled with mass spectrometry (SUPRA-MS): proof of concept of on-chip characterization of a potential breast cancer marker in human plasma

21 January 2018

1 reference

Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS.

21 January 2018

1 reference

Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry

21 January 2018

1 reference

Tumor classification of six common cancer types based on proteomic profiling by MALDI imaging.

21 January 2018

1 reference

Protein unlocking procedures of formalin-fixed paraffin-embedded tissues: application to MALDI-TOF imaging MS investigations

21 January 2018

1 reference

Citric acid antigen retrieval (CAAR) for tryptic peptide imaging directly on archived formalin-fixed paraffin-embedded tissue

21 January 2018

1 reference

Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation.

21 January 2018

1 reference

Protein biomarker discovery and validation: the long and uncertain path to clinical utility

21 January 2018

1 reference

Mass spectrometric characterization of protein structure details refines the proteome signature for invasive ductal breast carcinoma.

21 January 2018

1 reference

Proteome profiling of breast tumors by gel electrophoresis and nanoscale electrospray ionization mass spectrometry.

21 January 2018

1 reference

Proteomic approach reveals FKBP4 and S100A9 as potential prediction markers of therapeutic response to neoadjuvant chemotherapy in patients with breast cancer

21 January 2018

1 reference

Do serum biomarkers really measure breast cancer?

21 January 2018

1 reference

Protein chip discovery of secreted proteins regulated by the phosphatidylinositol 3-kinase pathway in ovarian cancer cell lines

21 January 2018

1 reference

Proteomic analyses reveal high expression of decorin and endoplasmin (HSP90B1) are associated with breast cancer metastasis and decreased survival

21 January 2018

1 reference

Targeted proteomics for validation of biomarkers in clinical samples

21 January 2018

1 reference

Biomarker validation in blood specimens by selected reaction monitoring mass spectrometry of N-glycosites

21 January 2018

1 reference

National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers

21 January 2018

1 reference

A recipe for proteomics diagnostic test development: the OVA1 test, from biomarker discovery to FDA clearance

21 January 2018

1 reference

Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma

21 January 2018

1 reference

Detection and identification of potential biomarkers of breast cancer.

21 January 2018

1 reference

Differential exoprotease activities confer tumor-specific serum peptidome patterns

21 January 2018

1 reference

Targeted mass spectrometry approaches for protein biomarker verification

21 January 2018

1 reference

Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer

21 January 2018

1 reference

Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value.

21 January 2018

1 reference

Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients

21 January 2018

1 reference

Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarker

21 January 2018

1 reference

Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers

21 January 2018

1 reference

iTRAQ protein quantification: A quality-controlled workflow

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EPR.12.62

1 reference

28 August 2017

1 reference

PubMed ID

23256671